this week

List

March 16th, 2011

Bactrim Over The Counter

[This review was originally posted at the Nieman Journalism Lab Bactrim Over The Counter, on March 11, 2011.]

A bad week for NPR execs named Schiller: For the second time in five months, NPR has found itself in the middle of a controversy that's forced it to wrestle with issues of objectivity, bias, and its own federal funding. This one started when the conservative prankster James O'Keefe orchestrated a hidden-camera video of a NPR fundraising exec bashing Tea Partiers and generally straying from the NPR party line while meeting with people pretending to represent a Muslim charity. (The "donors" also met with PBS, but their people didn't take the bait.)

Reaction was mixed: The right, of course, was outraged, Where can i cheapest Bactrim online, though others like Slate's Jack Shafer and Gawker's John Cook downplayed the significance of the video. NPR was outraged, too — "appalled," actually, and CEO Vivian Schiller said she was upset and that the two execs had put on administrative leave. Within about 12 hours, however, Bactrim use, Schiller herself had been forced out by NPR's board. The New York Times has good background on the shocking turn of events, and Poynter summarized the six months of controversy that led up to this, stretching back to Juan Williams' firing (the American Journalism Review's Rem Rieder called Schiller's ouster "Williams' revenge"), Bactrim Over The Counter.

Reaction to NPR's handling of the situation was decidedly less mixed — and a lot more scathing. In a chat and column, NPR ombudsman Alicia Shepard ripped just about all parties involved, and the online response from media-watchers was just as harsh. Bactrim for sale, NYU j-prof Jay Rosen called it "profoundly unjust," and several others blasted NPR's leadership.

The Awl's Choire Sicha called NPR's management "wusses," CUNY j-prof Jeff Jarvis called the NPR board "ballless" and said the episode exposes the difference between NPR and the stations who run it, ex-Saloner Scott Rosenberg lamented NPR's allowing the O'Keefes of the world to take over public discourse, and Rosen and Northeastern j-prof Dan Kennedy told NPR to start fighting back. The Columbia Journalism Review's Joel Meares put it best Bactrim Over The Counter, , saying the fiasco "exposes them as an organization that is fundamentally weak—too concerned about its image to realize that 'surrender' is not always the best option."

The episode also stoked the fires of the perpetual debate over whether public radio should keep its federal funding. The Atlantic's Chris Good looked at the political aspects of the issue, Bactrim natural, and The Christian Science Monitor examined whether public radio stations would survive without federal money. A few calls to defund public radio came from outside the traditional (i.e. conservative) places, with Gawker's Hamilton Nolan and media analyst Alan Mutter arguing that NPR will be in an untenable situation as a political football as long as they're getting federal funds. Meanwhile, Where to buy Bactrim, here at the Lab, USC's Nikki Usher did give some encouraging information from the whole situation, looking at Schiller's legacy of digital and local innovation during her NPR tenure.

—

Making hyperlocal news personal: AOL continued its move into local news late last week, as it bought the hyperlocal news aggregator Outside.in, Bactrim Over The Counter. In an excellent analysis at the Lab, Ken Doctor argued that the purchase is a way for AOL to get bigger quickly, particularly by bulking up Patch's pageviews through cheap local aggregation tools. ReadWriteWeb's Marshall Kirkpatrick took the opportunity to ask why hyperlocal news technology services like Outside.in, Bactrim maximum dosage, Everyblock, and Fwix haven't been as useful as we had hoped.

Mathew Ingram of GigaOM posited an answer: Hyperlocal journalism only works if it's deeply connected with the community it serves, and those technologies aren't. Without that level of community, "AOL is pouring money into a bottomless pit, Bactrim used for, "he wrote. The Knight Digital Media Center's Amy Gahran said that might be where local news organizations can step in, focusing less on creating news articles and more on using their community trust to make local information useful, relevant and findable.

Elsewhere on the cheap-content front: All Things Digital reported that AOL is laying off hundreds of employees (including the widely expected gutting of several of its news sites), and Business Insider snagged the memo. Wired talked to two Google engineers Bactrim Over The Counter, about its anti-content farm changes, and Wikipedia founder Jimmy Wales said good content is created either by passionate fans or by proper journalists being paid a fair amount. But, he said, Bactrim description, "paying people a very low amount of money to write about stuff they don't care about — that doesn't work." And Dan Conover at Xark warned against turning content — especially hyperlocal — into a franchise formula.

—

Accountability and authenticity in online comments: TechCrunch was one of the first companies to try out Facebook's new commenting system, and after about a week, MG Siegler noted that the number of the site's comments had decreased, and they'd also gone from nasty to warm and fuzzy. Buy Bactrim without a prescription, Entrepreneur Steve Cheney proposed a reason why the comments were so "sterile and neutered": Facebook kills online authenticity, because everyone is self-censoring their statements to make sure their grandmas, ex-girlfriends, and entire social network won't be offended.

Tech guru Robert Scoble disagreed, arguing that TechCrunch's comments have improved, and people know real change and credibility only comes from using their real identities. Slate's Farhad Manjoo made a somewhat similar argument, Bactrim interactions, eloquently making the case for the elimination of anonymous commenting. GigaOM's Mathew Ingram weighed in by saying that Facebook can't make or break comments — it all depends on being involved in an actual conversation with users, Bactrim Over The Counter. He pointed to a brilliant post by NPR's Matt Thompson, who gave numerous tips on cultivating community in comments; much it went back to the idea that "The very best filter is an empowered, engaged adult."

Meanwhile, Joy Mayer of the Reynolds Journalism Institute got some advice on cultivating online reader engagement from the Wall Street Journal's Zach Seward, Ordering Bactrim online, and the Lab's Megan Garber reported on the results of some research into which stories are the most liked and shared on Facebook.

—

More paywall test cases: Newspapers continue to pound the paywall drumbeat, with the CEO of newspaper chain Gannett saying the company is experimenting with various pay models in anticipation of a potential one-time company-wide rollout and the Dallas Morning News rolling out its own paywall this week. Ken Doctor crunched the numbers to try to gauge the initiative's chances, and media consultant Mike Orren disagreed with the News' idea of how much a metro newspaper's operation should cost.

Elsewhere, Reuters' Felix Salmon made the case that Britain's Financial Times' paywall strategy has contributed to its decline, what is Bactrim, writing,"the FT strategy is exactly the strategy I would choose if I was faced with an industry in terminal decline, and wanted to extract as much money as possible from it before it died." Meanwhile, The New York Times' public editor, Arthur Brisbane, Buy cheap Bactrim, chided the Times for not aggressively covering news of its own paywall, and Mathew Ingram of GigaOM called paywalls a futile attempt to hold back the tide of free online content.

—

Reading roundup: Some things to read in between South by Southwest Interactive panels:

— Newsweek published its first redesigned issue Bactrim Over The Counter, under The Daily Beast's Tina Brown this week. The Society of Publication Designers had a look at the issue, which Slate's Jack Shafer panned. The New York Times noted the issue's familiar bylines.

— A few Apple-related notes: At MediaShift, Susan Currie Sivek looked at the impact of Apple's 30% app subscription cut on small magazines, online buying Bactrim, and Poynter's Damon Kiesow urged Apple-fighting publishers to move to the open web, not Android-powered tablets. GigaOM's Om Malik joined the chorus of people calling for iPad apps to be reimagined.

— Two great posts at the Lab on search engine optimization: Richard J, Bactrim Over The Counter. Tofel on why the web will be better off with the decline of SEO, and Martin Langeveld on the SEO consequences of including paid links on sites. Buy generic Bactrim, — Former Guardian digital chief Emily Bell gave a fantastic interview to CBC Radio about various future-of-news issues, and Mathew Ingram summarized a talk she gave on newspapers and the web.

— Finally, two must-reads: The Atlantic's James Fallows wrote a thoughtful essay arguing that we should take the contemporary journalism environment on its own terms, rather than unfairly comparing it to earlier eras. And at the Lab, former St. Pete Times journalist and current Nebraska j-prof Matt Waite called news developers to let the old systems go and "hack at the very core of the whole product.".

March 16th, 2011

Bactrim No Rx

[This review was originally posted at the Nieman Journalism Lab Bactrim No Rx, on Feb. 25, 2011.]

The short, happy-ish life of TBD: Just six months after it launched and two weeks after a reorganization was announced, the Washington, D.C., local news site was effectively shuttered this week, where can i buy cheapest Bactrim online, when its corporate parent, Allbritton Communications (it's owned by Robert Allbritton and includes Politico), cut all of its jobs, leaving only an arts and entertainment operation within the website of Allbritton's WJLA-TV.

TBD had been seen many as a bellwether in online-only local news, After Bactrim, as Poynter's Mallary Jean Tenore documented in her historical roundup of links about the site, so it was quite a shock and a disappointment to many future-of-newsies that it was closed so quickly. The response — aptly compiled by TBDer Jeff Sonderman — was largely sympathetic to TBD's staff (former TBD manager Jim Brady even wrote a pitch to prospective employers on behalf of the newly laid off community engagement team). Many observers on Twitter (and Terry Heaton on his blog) pointed squarely at Allbritton for the site's demise, with The Batavian's Howard Owens drawing out a short, thoughtful lesson: "Legacy managers will nearly always sabotage innovation. Wall of separation necessary between innovators and legacy."

Blogger Mike Clark pointed out that TBD's traffic was beating each of the other D.C. TV news sites and growing as well, Bactrim No Rx. The Washington Post reported that while traffic wasn't a problem, Bactrim blogs, turning it into revenue was — though the fact that TBD's ads were handled by WJLA staffers might have contributed to that.

Mallary Jean Tenore wrote an insightful article talking to some TBD folks about whether their company gave them a chance to fail. Lehigh j-prof Jeremy Littau was unequivocal on the subject: "Some of us have been talking today on Twitter about whether TBD failed. Nonsense. TBD wasn’t given enough time to fail."

While CUNY j-prof Jeff Jarvis lamented Bactrim No Rx, that "TBD will be painted as a failure of local news online when it's a failure of its company, nothing more," others saw some larger implications for other online local news projects. Media analyst Alan Mutter concluded that TBD's plight is "further evidence that hyperlocal journalism is more hype than hope for the news business, Order Bactrim from United States pharmacy, " and Poynter's Rick Edmonds gave six business lessons for similar projects from TBD's struggles. Journal Register Co. CEO John Paton ripped Edmonds' analysis, arguing that Allbritton "can’t pretend to have seriously tried the hyperlocal business space after a six-month experiment it derailed half-way in."

—

Applying Apple's new rules: Publishers' consternation over Apple's new subscription plan for mobile devices continued this week, with Frederic Filloux at Monday Note laying out many publishers' frustrations with Apple's proposal. The New York Times' David Carr and The Guardian's Josh Halliday both covered publishers' Apple subscription conundrum, and one expert told Carr, Bactrim over the counter, "If you are a publisher, it puts things into a tailspin: The business model you have been working with for many years just lost 30 percent off the top."

At paidContent, James McQuivey made the case for a lower revenue share for Apple, and Dan Gillmor wondered whether publishers will stand up to Apple. The company may also be facing scrutiny from the U.S, Bactrim No Rx. Justice Department and Federal Trade Commission for possible antitrust violations, Buy Bactrim without a prescription, The Wall Street Journal reported.

The fresh issue regarding Apple's subscription policy this week, though, was the distinction between publishing apps and more service-oriented apps. The topic came to the fore when the folks from Readability, an app that allows users to read articles in an advertising-free environment, wrote an open letter ripping Apple for rejecting their app, buying Bactrim online over the counter, saying their new policy "smacks of greed." Ars Technica's Chris Foresman and Apple blogger John Gruber noted, though, that Readability's 30%-off-the-top business model is a lot like Apple's.

Then Apple's Steve Jobs sent a short, cryptic email to a developer saying that Apple's new policy applies only to publishing apps, Rx free Bactrim, not service apps. Bactrim No Rx, This, of course, raised the question, in TechCrunch's words, "What's a publishing app?" That's a very complex question, and as Instapaper founder Marco Arment wrote, one that will be difficult for Apple to answer consistently. Arment also briefly noted that Jobs' statement seems to contradict the language of Apple's new guidelines.

—

Giving voice to new sources of news: This month's Carnival of Journalism, posted late last week, focused on ways to increase the number of news sources. It's a broad question, and it drew a broad variety of answers, Bactrim schedule, which were ably summarized by Courtney Shove. I'm not going to try to duplicate her work here, but I do want to highlight a few of the themes that showed up.

David Cohn, the Carnival's organizer, gave a great big-picture perspective to the issue, putting it in the context of power and the web. Kim Bui and Dan Fenster defended the community-driven vision for news, with Bui calling journalists to go further: "Let’s admit it, we’ve never trusted the public." There were several calls for journalists to include more underrepresented voices, with reports and ideas like a refugee news initiative, digital news bus, youth journalism projects, and initiatives for youth in foreign-language families, Bactrim No Rx.

The J-Lab's Jan Schaffer gave 10 good ideas to the cause, and Drury j-prof Jonathan Groves and Gannett's Ryan Sholin shared their ideas for local citizen news projects, Bactrim australia, uk, us, usa, while TheUpTake's Jason Barnett endorsed a new citizen-journalism app called iBreakNews.

Three bloggers, however, objected to the Carnival's premise in the first place. Daniel Bachhuber of CUNY argued that improving journalism doesn't necessarily mean adding more sources, recommending instead that "Instead of increasing the number of news sources, we should focus on producing durable data and the equivalent tools for remixing it." Lauren Rabaino warned against news oversaturation, order Bactrim no prescription, and the University of Colorado's Steve Outing said that more than new sources, we need better filters and hubs for them.

—

Blogging's continued evolution: The "blogging is dead" argument has popped up from time to time, and it was revived again this week in the form of a New York Times story about how young people are leaving blogs for social networking sites like Facebook and Twitter. Bactrim No Rx, Several people countered the argument, led by GigaOM's Mathew Ingram, who said that blogging isn't declining, but is instead evolving into more of a continuum that includes microblogging services like Twitter, traditional blog formats like Wordpress, and the hybrid that is Tumblr. He and Wordpress founding developer Matt Mullenweg shared the same view — that "people of all ages are becoming more and more comfortable publishing online," no matter the form.

Scott Rosenberg, who's written a history of blogging, looked at statistics to make the point, noting that 14% of online adults keep a blog, buy Bactrim online no prescription, a number he called astounding, even if it starts to decline. "As the online population becomes closer to universal, that is an extraordinary thing: One in ten people writing in public. Our civilization has never seen anything like it." In addition, Bactrim treatment, Reuters' Anthony DeRosa argued that longer-form blogging has always been a pursuit of older Internet users.

—

Reading roundup: I've got a few ongoing stories to update you on, and a sampling of an unusually rich week in thoughtful pieces.

— A couple of sites took a peek at Gawker's traffic statistics to try to determine the effectiveness of its recent redesign, Bactrim No Rx. TechCrunch saw an ugly picture; Business Insider was cautiously optimistic based on the same data. Gawker disputed TechCrunch's numbers, and Terry Heaton tried to sort through the claims.

— A couple of Middle East/North Africa protest notes: The New York Times told us about the response to Egypt's Internet blackout and the role of mobile technology in documenting the protests, is Bactrim safe. And Amy Gahran of the Knight Digital Media Center gave some lessons from the incredible Twitter journalism of NPR's Andy Carvin.

— The Daily is coming to Android tablets Bactrim No Rx, this spring, and its free trial run has been extended beyond the initial two weeks.

— Matt DeRienzo of the Journal Register Co. wrote about an intriguing idea for a news org/j-school merger.

— Alan Mutter made the case for ending federal funding for public journalism.

— At 10,000 Words, Lauren Rabaino had some awesome things news organizations can learn from tech startups, including thinking of news as software and embracing transparency.

— And here at the Lab, Northwestern prof Pablo Boczkowski gave some quick thoughts on how we tend to associate online news with work, and what that means. He sheds some light about an under-considered aspect of news — the social environments in which we consume it.

February 18th, 2011

Flagyl Price

[This review was originally posted at the Nieman Journalism Lab Flagyl Price, on Feb. 18, 2011.]

Apple lays down its terms: Publishers have been quite anxiously awaiting word from Apple about the particulars of its subscription plan for mobile devices including the iPad; they got it this week, but it wasn't what a lot of them were hoping for. The New York Times summarized publishers' initial reaction with a few of the basic details — Apple gets a 30 percent cut, owns subscriber data (whether to send data to publishers is up to the subscriber), Get Flagyl, and publishers' options for subscription services outside Apple are limited.

The Lab's Josh Benton aptly laid out some of the primary implications for news organizations: Apple is setting itself up as toll-taker on the new news highway and putting a heavy incentive on converting print readers to tablet readers, but not putting restrictions on browser access within its devices. Media analyst Ken Doctor offered two astute takes on what Apple's proposal will entail; we'll call them glass-half-full and glass-half-empty.

Most of the reaction to Apple's deal, however, was overwhelmingly negative, Flagyl Price. Media consultant Alan Mutter pointed out a couple of gotchas for publishers, Dan Gillmor called Apple's policy stunningly arrogant and the publishers that sign up for it "insane, or desperate, Flagyl from mexico," ITworld's Ryan Faas called it "gouging content producers," Gizmodo's Matt Buchanan dubbed it "evil," developer Ryan Carson urged users to fight Apple's "extortion," and a Wall Street Journal raised possible antitrust issues.

The beef that most of these critics have with Apple is not so much the 30 percent cut (though that's part of it) as it is Apple's restrictions on publishers' alternative subscription methods. Effects of Flagyl, Apple is requiring that publishers that want to have a non-App Store subscription method can't charge less than their Apple-sanctioned route, and can't show app users how to access it, either. This means that, as Buchanan states, "Effectively, all easy roads to getting content on the iPad now run through Apple." (Plus, where can i buy Flagyl online, as TechCrunch's Erick Schonfeld noted, those terms could easily become even worse once Apple has publishers and readers hooked.)

Of course, the system looks a bit different from the consumer's perspective — it may be the most user-friendly subscription system ever, argued MG Siegler of TechCrunch. Flagyl Price, (Publishers, of course, disagreed about that.) As GigaOm's Mathew Ingram pointed out, this may come down to how much publishers think it's worth to have Apple handle their mobile sales for them.

We got some mixed early signs about how publishers might answer that question. Purchase Flagyl, PaidContent reported on publishers who felt Apple's terms could have been much worse, and Poynter's Damon Kiesow talked to publishers who plan to offer multiple options. Popular Science became the first magazine to jump on board and Wired is following ASAP, but Time Inc. pre-emptively struck deals with Apple's competitors, and another publishers' group threatened to take its business elsewhere.

—

One Pass to rule them all?: As if to underscore that point, Google announced its own One Pass digital paid-content system the next day, Flagyl dangers. Unlike Apple, Google will keep about 10 percent of publishers' revenue and allow publishers to own their subscribers' data, according to Advertising Age, Flagyl Price. Much of the commentary about Google's plan positioned it in opposition to Apple's proposal: The Wall Street Journal described it as a fired salvo at Apple, search guru John Battelle summed it up as "Hey Apple, we've got a better way," Alan Mutter detailed the ways Google's plan "trumps" Apple's, and others from The Next Web, Flagyl dose, mocoNews, and Fast Companycompared the two proposals.

But several others — particularly the Lab's Josh Benton and Poynter's Rick Edmonds — explained that while it might seem natural to compare Google's system to Apple's given the timing of their announcements, Google One Pass is focused far more on web access than app access, making the paid-content company Journalism Online a more direct competitor than Apple. Journalism Online's Gordon Crovitz made the case to paidContent for his company over Google, highlighting its flexibility, and paidContent also noted that newspaper chain MediaGeneral is trying out both systems at different papers, Flagyl description.

A couple of other notes on Google's plan: TechCrunch's MG Siegler argued that Google's agreement to allow publishers ownership of subscribers' data is at least as big of a deal to publishers as the revenue split, and GigaOM's Mathew Ingram ripped One Pass, saying that as long as its clients' content is on the open web without the exceptional user experience of the best apps, it's just "a warmed-over content paywall."

—

Parsing out the 'social media and revolutions' debate: Despite having been declared "over" early this week by The Daily's editor-in-chief, the protests in Egypt continued to dominate conversation, Purchase Flagyl online, including in future-of-news circles. Via The New York Times, we got a glimpse into how Egyptian officials were able to shut down their country's Internet and Facebook is wrestling with its role in the protests. NPR's Andy Carvin continued to earn plaudits (from The New York Times and PR exec Katie Delahaye Flagyl Price, ), and the Lab's Megan Garber looked at the way Carvin spontaneously launched a personalized Twitter pledge drive.

But the bulk of the discussion revolved around the same discussion that's been on slow burn for the past few weeks: What role does social media play in social activism. Washington grad student Deen Freelon has once again produced a fantastic synopsis of what we know and what we have yet to learn in this arena, so consider this a supplement to his post.

The parade of articles arguing that Twitter doesn't cause revolutions continued at a steady pace this week, Flagyl steet value, prompting NYU j-prof to profile the Twitter-debunking article as a genre, concluding that that argument — along with the glib social media triumphalism it's refuting — is a cheap detour around actually thoughtfully considering the complex issues involved in social change. Several others built on Rosen's point: Aaron Bady delved deeper into the social media-debunking article's function, CUNY j-profs Jeff Jarvis and C.W. Anderson focused on protecting those technological tools, and opined on the difference between academic and popular discourse on cause-and-effect, Flagyl brand name, respectively.

That doesn't there aren't substantive things to say about social media's role in recent protests, of course, Flagyl Price. POLIS' Charlie Beckett noted that newly adopted technologies (such as mobile phones) have helped create a more "networkable" power structure in the Middle East, and NDN's Sam duPont looked at social media's role as organizing tool, news source, and public sphere in Egypt.

—

To pay or not to pay: With a few exceptions (Frederic Filloux's short, fierce takedown of The Huffington Post as a "digital sand castle" is well worth a read), Flagyl forum, the second week of commentary on AOL's purchase of The Huffington Post centered on the question of whether HuffPo's thousands of unpaid contributors should start getting paychecks for their work.

At The New York Times' FiveThirtyEight blog, Nate Silver attempted to calculate the worth of a typical HuffPo post, concluding that they follow a classic power law relationship and that most of them aren't worth much. The New York Observer's Ben Popper said Silver is undervaluing HuffPo's contributors, Where can i cheapest Flagyl online, and Gannett's Ryan Sholin made the point that having those posts within a single platform is worth more than the posts themselves. Flagyl Price, Most of the grist for this week's conversation, though, came from Silver's Times colleague, David Carr, who used HuffPo as an entree into some observations about creating online content for others for free through platforms like Facebook, Twitter, and Quora. Paul Gillin of Newspaper Death Watch built on Carr and Silver's analyses to make the case that in the face of devalued online content, demand for higher-quality material might bring us out of the basement of online pay.

Several others countered Carr with similar points: Web thinker Stowe Boyd, British j-prof Paul Bradshaw and HuffPo's own Nico Pitney said HuffPo bloggers have eminently legitimate non-monetary reasons for writing there, GigaOM's Mathew Ingram pointed out that The Times' op-ed system isn't much different from HuffPo's, and Jeff Jarvis said news folks should be thinking more about value than content, order Flagyl online c.o.d.

—

Reading roundup: Some interesting bits and pieces to round out the week:

— Google unveiled the latest tool in its effort to fight content farms this week — an extension to its browser, Chrome, that allows users to block any site they choose from Google search results. TechCrunch called it "crowdsourcing" their content farm detection, and Gizmodo said that it allows for the arresting possibility of "an internet that never disagrees with you."

— A few miscellaneous items regarding The Daily: Slate's chairman, Herbal Flagyl, Jacob Weisberg, ripped it ("It’s just a bad version of a newspaper in electronic form with a very condescending view of the audience"), Scott Rosenberg wondered what'll happen to its archives, and the publication updated its glitch-ridden app.

— A couple of great data journalism resources: Poynter's Steve Myers broke down the difficulties in integrating data journalism into the newsroom, and ProPublica's Dan Nguyen wrote a wonderful post encouraging journalists to get started with data analysis, Flagyl Price.

— The second blogging Carnival of Journalism, focusing on increasing the number of news sources within communities, began going up over the past day or so, so keep an eye out for those posts. I'll have a roundup here next week.

— If you want a 30,000-foot summary of what's happening on the leading edge of news right now, you really can't do much better than Josh Benton's speech posted here at the Lab. It's a fantastic primer, no matter how initiated you already are.

February 18th, 2011

Glucophage Price

[This review was originally posted at the Nieman Journalism Lab Glucophage Price, on Feb. 11, 2011.]

AOL scoops up Arianna: The week's biggest media story was broken just a couple of hours after the Super Bowl on Sunday, when Kara Swisher of All Things D reported that AOL would buy The Huffington Post for $315 million (here's video of her interview with Arianna Huffington and AOL CEO Tim Armstrong). Swisher's post and this New York Times article provide just about all the background information you should need on the deal, along with The Huffington Post's press release and Huffington's column on the acquisition. Glucophage canada, mexico, india, The deal was seen by many as a bold one — a "fourth-quarter Hail Mary pass," as The New Yorker's Ken Auletta wrote — and reaction on the web (also summed up well by GigaOM's Mathew Ingram) was decidedly mixed. The thumbs-ups came from a eclectic mix of critics: Henry Blodget of Business Insider called it a smart risk, Reuters' Felix Salmon and All Things D's Peter Kafka said the two companies' needs fit each other well, with AOL getting a clear editorial voice (Salmon) and a "content-making machine" (Kafka). CUNY j-prof Jeff Jarvis said what AOL will find most valuable in HuffPo will not be content, but "a new cultural understanding of media that is built around the value of curation, the power of peers, the link economy, passion as an asset, and celebrity as a currency."

There were also plenty of people who shook (or at least scratched) their heads at the deal, including many of HuffPo's own readers and writers, Glucophage Price. Shira Ovide of The Wall Street Journal called it AOL's admission that its content strategy isn't working, and industry analyst Alan Mutter said AOL overpaid, online buy Glucophage without a prescription. The Guardian's Jemima Kiss blasted the move as "soullessly commercial," and Salon vet Scott Rosenberg contended that Huffington's once-distinctive brand will dissolve into AOL's bland corporatism. PaidContent's David Kaplan, Dan Lyons, and Om Malik of GigaOM both pointed to advertising struggles, Discount Glucophage, with Malik arguing that AOL has "not yet come to terms with the futility of chasing page views."

A few themes came up repeatedly in commentary about the two companies; one was HuffPo's expertise in that notorious (some would say dark) art known as search engine optimization. Salon's Alex Pareene declared the new organization "the single largest SEO-gaming operation ever created" and the LA Times' James Rainey explained the appeal that the Post's SEO skills bring. Slate's Farhad Manjoo (who wins this week's award for best lead) made the case that AOL/HuffPo's SEO-heavy strategy is risky in the long-term because "they won't be able to fool the computers forever." (Capital New York's Tom McGeveran made a similar point Glucophage Price, .) HuffPo's new AOL corporate empire-mate, Paul Carr of TechCrunch, reaffirmed his hatred for HuffPo's SEO tactics but said the deal could still be a good one for AOL.

The second theme was the fact that the Post doesn't pay most of its writers, a strategy that Tim Rutten of the Los Angeles Times likened to "a galley rowed by slaves and commanded by pirates." Dan Gillmor's tone was a bit milder, but he, Glucophage samples, too, urged Huffington to start paying her most productive bloggers, and Northeastern j-prof Dan Kennedy wondered whether bloggers might be less willing to go unpaid under a mega-corporation like AOL. Reason's Matt Welch defended Huffington against Rutten's charges, and Time's James Poniewozik said it's possible AOL/HuffPo could be signaling a move toward more expensive, Australia, uk, us, usa, quality content.

A few miscellaneous pieces of sharp commentary: GigaOM's Mathew Ingram said AOL needs HuffPo to help its other online content initatives figure out how the Internet works, and media analyst Ken Doctor saw AOL/HuffPo as a potential free alternative to Rupert Murdoch's steadily building paid-content empire. There were also plenty of posts about what the political viewpoint of the new organization would be, and while I haven't waded into that discussion, I do like NYU j-prof Jay Rosen's concept of "ideological innovation" in online journalism.

—

Changing coverage of a changing world: As the protests in Egypt have continued, so has the conversation about its media-related implications, and just as in last week, much of the talk centered on Al Jazeera, Glucophage Price. The New York Times examined the network's influence on the protests, Glucophage natural, as well as its efforts to gain more access to American viewers. Throughout the past two weeks, as the Lab's Justin Ellis and Twitter's Robin Sloan pointed out, Al Jazeera has been using social media to distribute its news to American audiences. Meanwhile, Glucophage overnight, Sheila Carapico at Foreign Policy argued that Al Jazeera and other TV networks can't give us a full picture of what's going on in Egypt.

There's been other fantastic journalism arising from the Egyptian protests, including the work of NPR's Andy Carvin to curate news and voices of the conflict on Twitter. Glucophage Price, In an illuminating interview with The Atlantic, Carvin argued that curation — the process of capturing the most elements of a story from various sources and passing them along — has always been a part of journalism. In a more academic piece at the Lab, USC grad student Nikki Usher explained how the protests are expanding the idea of a media event, with social media, webstreams, Glucophage cost, and the mainstream media "all working together to create a much larger, more nuanced picture of the live broadcasting of history."

The debate over social media's role in revolutions continued to roil, with several more writers responding to Malcolm Gladwell's brief New Yorker post arguing that the role Twitter & Co. in social activism like the Egyptian protests is overrated. UT-Dallas prof David Parry, Glucophage images, The Awl's Maria Bustillos, new media exec Rex Hammock, UMBC prof Zeynek Tufekci, and web philosopher David Weinbergerall weighed in with their rejoinders to Gladwell, in a discussion that Washington grad student Deen Freelon has mapped out far more expertly than I could.

—

Speeding up The Daily: The negative buzz around The Daily that began last week continued to pile up this week, leading to, Glucophage use, among other things, a "We're listening" blog post by the new "tablet newspaper." One of the issues that drew criticism was The Daily's long load time, as John Gruber of Daring Fireball compared it unfavorably to Flipboard, and paidContent's Staci Kramer explained her own loading glitches. Both Gruber and Kramer argued that while it seem minor, load time is a big deal to users, and The New York Times' Nick Bilton made a similar point: By being too slow and bulky, digital magazines like The Daily "almost defeat one of their main intended purposes, the promise of instant access to content and information."

The reviews kept pouring in as well, led by an insightful critique of The Daily's design by Stephen Coles at Fonts In Use, Glucophage Price. The primary criticism continued in the same vein as last week: The Daily's content just doesn't cut it. John Gapper of the Financial Times and Skip Ferderber of Crosscut made the point this week, Glucophage wiki, and Poynter's Damon Kiesow noted that new content is tough to find. Paul Davis of Shareable also chimed in with a criticism of The Daily's shortcomings with limited sharing options.

But there were a few who were generally impressed with The Daily's first week, including MinnPost's John Dreinan and industry analyst Alan Mutter, who liked its concise storytelling, multimedia integration and interactive advertising. Damon Kiesow and The Columbia Journalism Review's Lauren Kirchner both looked to other media efforts for lessons for The Daily — Kiesow to various other iPad apps, and Kirchner to the mid-1990s debut of Slate and Salon, Glucophage no prescription.

—

Gawker evolves the blog: We've been hearing about it since November, and this week Gawker officially launched its redesign, which reflects to a more magazine-style emphasis from a purer blog format. The Lab's Megan Garber captured what the move means Glucophage Price, particularly in terms of Gawker's advertising strategy, explaining how it's appropriated parts of the TV and magazine models to capitalize on its brand as a whole: "It’s moved, it seems, beyond simply selling its readers to advertisers. Now, it is simply selling itself."

Former Gawker Media contributor Latoya Peterson pointed to the outrage by Gawker blogs' readers and used it to argue that Gawker's new, My Glucophage experience, more controlled design is subverting the fast-posting, skim-friendly style it helped make a blogging standard. Rex Sorgatz was also skeptical of the change, asserting that the redesign would have to be rolled back or reworked within months and challenging anyone to bet him otherwise — a wager that was taken up by Gawker chief Nick Denton himself, using pageviews as the determining factor.

—

TBD takes a step back: TBD, a online local news operation based in Washington, real brand Glucophage online, D.C., debuted last August to much fanfare, but it took a major hit when the Washington Post reported that its owner Robert Allbritton (who also owns Politico) would have his local TV station WJLA take it over. TBD editor-in-chief Erik Wemple told the Lab's Megan Garber that the move wouldn't be as bad as it appeared, but it was still widely interpreted as "a retreat from the original vision of TBD, Purchase Glucophage online no prescription, " in the Post's words. Jim Brady, the site's former general manager, called it "not good news," and NYU j-prof Jay Rosen summed it up as "the TV guys won."

In the wake of the news, several observers expressed their frustration: Media consultant Mark Potts ripped Allbritton for not allowing the site breathing room to innovate, and media analyst Janet Coats held it up as an example of old media's resistance to change. Terry Heaton and Lost Remote's Cory Bergman used the episode to talk about the tensions involved when TV stations are affiliated with online media efforts, Glucophage Price.

—

Reading roundup: There's still quite a bit to get to, but I'll run through it quickly:

— Re Wikileaks: New York Times executive editor Bill Keller edged toward defining WikiLeaks as something a lot like journalism, The Nation's Greg Mitchell explained why the mainstream media is skeptical of WikiLeaks, the Personal Democracy Forum's Micah Sifry and NYU prof Clay Shirky gave some reasons for WikiLeaks' revolutionary nature, and at The Guardian, Evgeny Morozov argued that WikiLeaks can't continue much longer in its current form.

— Yahoo announced a move toward more personal content, particularly tablet-based. The New York Times explained why.

— At the National Sports Journalism Center, Jason Fry wrote a wonderful piece talking about how much less valuable scoops have become in a commoditized news world, and what journalists should do as a result. Craig Calcaterra of the baseball blog Hardball Talk expanded on the idea, offering a vision for the role of bloggers and reporters in a commodity-news environment.

— Two pieces to chew on this weekend, one short and one long: Dave Winer's plea to news organizations to join their communities online, and The New Yorker's Adam Gopnik's musings on the Internet and our interior lives.

February 18th, 2011

Bactrim Cost

[This review was originally posted at the Nieman Journalism Lab Bactrim Cost, on Feb. 4, 2011.]

Al Jazeera, the network, and social activism: For the last week, the eyes of the world have been riveted to the ongoing protests in Egypt, and not surprisingly, the news media themselves have been a big part of that story, Bactrim interactions, too. Many of them have been attacked by President Hosni Mubarak's lackeys, but the crisis has also been a breeding ground for innovative journalism techniques. Mashable put together a roundup of the ways journalists have used Twitter, Facebook, streaming video, Bactrim without a prescription, Tumblr, and Audioboo, and the Lab highlighted reporting efforts on Facebook, curation by Sulia, and explainers by Mother Jones. Google and Twitter also created Speak to Tweet to allow Egyptians cut off from the Internet to communicate.

But the organization that has shined the brightest over the past 10 days is unquestionably Al Jazeera, Bactrim Cost. The Qatar-based TV network has dominated web viewing, and has used web audio updates and Creative Commons to get information out quickly to as many people as possible, Bactrim long term.

Al Jazeera also faced stiff censorship efforts from the Egyptian government, which stripped its Egyptian license and shut down its Cairo bureau, then later stole some of its camera equipment. Through it all, the broadcaster kept up live coverage that online and offline, was considered the most comprehensive of any news organization. Low dose Bactrim, As Lost Remote's Cory Bergman pointed, Al Jazeera's coverage showed the continued power of compelling live video in a multimedia world.

Salon's Alex Pareene called Al Jazeera's coverage Bactrim Cost, an indictment on the U.S.' cable networks, and CUNY j-prof Jeff Jarvis and others urged cable companies to carry Al Jazeera English. Tech pioneer Doc Searls used the moment as a call for a more open form of cable TV: "The message cable should be getting is not just 'carry Al Jazeera,' but 'normalize to the Internet.' Open the pipes. Give us à la carte choices. Let us get and pay for what we want, not just what gets force-fed in bundles."

The protests also served as fresh fuel for an ongoing debate about the role of social media in social change and global political activism. Several critics — including Wired's David Kravets, Bactrim no rx, The New Yorker's Malcolm Gladwell, and SUNY Oswego prof Ulises Mejias— downplayed the role of social media tools such as Twitter in protests like Egypt's. Others, though, countered with a relatively unified theme: It's not really about the media tools per se, but about the decentralized, hyperconnected network in which they are bound up. J-profs Jeremy Littau and Robert Hernandez, along with GigaOM's Mathew Ingram, wrote the most thoughtful versions of this theme, and they're all worth checking out, Bactrim Cost.

—

Tepid reviews for The Daily: Within the bubble of media geeks, one story dominated the others this week: On Wednesday, Rupert Murdoch's News Corp. released The Daily, the first daily updated news publication produced specifically for the iPad. Bactrim photos, If you can't get enough coverage of The Daily, go check out Mediagazer's smorgasbord of links. I'll try to offer you a digestible (but still a bit overwhelming, I'll admit) summary of what people are saying about it.

Leading up to Wednesday's launch, Poynter's Damon Kiesow found many of the people who are working for the heretofore secretive publication, and media analyst Alan Mutter and All Things Digital's Peter Kafka examined the reasons why it might or might not take off. Bactrim Cost, Once the app was released Wednesday afternoon, the reviews came pouring in.

First, buy Bactrim online cod, the good: The first impressions of most of the digital experts polled by Poynter were positive, with several praising its visual design and one calling it "what I’ve always hoped newspapers would do with their tablet editions." PaidContent's Staci Cramer was generally complimentary, and The Guardian's Ian Betteridge gave it a (not terribly enthusiastic) "buy."

Most of the initial reviews, though, were not so kind. Much of the 'meh' was directed at lackluster content, Where can i find Bactrim online, as reviewer after reviewer expressed similar sentiments: "a general-interest publication that is not generally interesting" (The Columbia Journalism Review); "Murdoch’s reinvention of journalism looks a lot like the one before it" (Macworld); "fairly humdrum day-old stories that you might read in, well…a regular old printed newspaper" (Mathew Ingram); "little [of Murdoch's money], it appears, has been invested in editorial talent" (Mashable); "the Etch A Sketch edition of Us Magazine" (Alan Mutter); "barely brings digital journalism into the late 20th century, much less the 21st" (Mark Potts).

The bulk of that criticism seemed to be built on two foundational questions, asked by the Lab's Joshua Benton, which The Daily has apparently yet to answer convincingly: "Who is The Daily trying to reach, order Bactrim from mexican pharmacy. What problem is it trying to solve?" TechCrunch (and several of the above reviewers) asked similar questions, and GigaOM's Darrell Etherington attempted an answer, arguing that it's not for the obsessively-Twitter-checking news junkies, but iPad users struggling to adjust to life after newspapers.

A few other issues surrounding The Daily that drew attention: One was its separation from the web by virtue of its place within the proprietary iTunes Store and iPad, as well as the complete lack of links in or out, Bactrim Cost. (That hasn't stopped an authorized daily index of links to the web versions of articles from springing up, though.) Salon alum Scott Rosenberg and j-prof Dan Kennedy led the charge against the walled garden, Bactrim dosage, while the Lab's Megan Garber pointed out the draconian anti-aggregation language on The Daily's AP content, and Justin Ellis wondered how user engagement will work in that closed environment.

Then there were the economics of the publication: Media analyst Ken Doctor had two good sets of questions about what it will take for The Daily to financially succeed (the latter is more number-crunchy). Jeff Jarvis also looked at some possible numbers, and media consultant Amy Gahran chastised Murdoch for investing so much money in the venture. Gahran also looked at the hazards of dealing with Apple, and paidContent's Staci Kramer noted that Murdoch wants Apple to lower its share of the subscription revenue. Bactrim Cost, And on the News Corp. front, Bactrim alternatives, Slate's Jack Shafer wrote about the role Murdoch's impatience will play in its fate, and Subhub's Evan Radowski gave us a history lesson on News Corp. initiatives like this one.

—

Apple strikes against e-publishers: In its ongoing tightening of App Store access and regulations, Apple made a significant move this week by rejecting a Sony iPhone app that would have allowed users to buy e-books from the Sony Reader Store. GigaOM's Mathew Ingram did a great job of putting the decision in the context of Apple's past moves, No prescription Bactrim online, explaining why they make good business sense: "What’s the point of controlling a platform like the iPhone and the iPad if you can’t force people to pay you a carrying charge for hosting their content and connecting them with their customers?"

But others (even at GigaOM) were more skeptical. Jason Kincaid of TechCrunch said the decision underscores the downside of closed content platforms, and posited that it's the first shot in a war between Apple and Amazon's Kindle, and Slate's Farhad Manjoo urged Amazon to pull its Kindle app out of the App Store. In another widely expected move along the same lines, Apple also told publishers that within two months, any app that doesn't take payments through its iTunes Store would be rejected, Bactrim Cost.

—

AOL follows Demand's content-farming path: We talked last week about Demand Media's explosive IPO and Google's intention to make content farms harder to find in searches, and we have a couple of updates to those issues this week. First, Seamus McCauley of Virtual Economics explained why he's skeptical about Demand's true valuation, not to mention its accounting methods, doses Bactrim work. And while Google's algorithm limiting content farms is not yet live, search engine startup Blekko has banned many content farm domains, including Demand's eHow, from its search results. Meanwhile, the debate over Demand continued, Buy no prescription Bactrim online, with Adotas' Gavin Dunaway and MinnPost's John Reinan delivering this week's broadsides against the company. Bactrim Cost, AOL hasn't been talked about as a content farm too much as of yet, but that may change after Business Insider's publication this week of a leaked internal document called "The AOL Way," which reads a lot like the textbook content farm strategy guide. GigaOM's Mathew Ingram and Fortune's Dan Mitchell blasted the plan, with Ingram asserting that "the chasing of eyeballs and pageviews is a game of constantly diminishing returns." Martin Bryant of The Next Web, on the other hand, said AOL's model is not a misguided, diabolical plan, but "an inevitable, turbo-powered evolution of what’s happened in the media industry for many years."

—

Reading roundup: A few things to check out this weekend while you're most likely snowed in somewhere:

— This week's WikiLeaks update: Julian Assange sat down with 60 Minutes for an interview (there's also a video on what it took to make that happen), buy cheap Bactrim, WikiLeaks was nominated for the Nobel Peace Prize, The Guardian's Alan Rusbridger gave his own account about working with WikiLeaks, and NYU's Adam Penenberg made the case for Assange as a journalist. Reuters also profiled the new WikiLeaks spinoff OpenLeaks.

— A few paid-content notes: The New York Times isn't releasing details of its paywall plan just yet, but it is fixing technological glitches with the system right now, while Media Week reported that some industry analysts are skeptical of its chances. Meanwhile, the Philadelphia Inquirer and Daily News announced they'll start offering an e-edition to paying subscribers.

— GigaOM founder Om Malik wrote a simple but insightful guide to creating a successful consumer Internet service, focusing on three elements: A clear purpose, ease of use, and fun.

— Harvard prof David Weinberger has a short, thought-provoking post offering a 21st-century update on Marshall McLuhan's famous "The medium is the message" aphorism: "We are the medium." It's a simple idea, but it has some potentially profound implications, a few of which Weinberger begins to flesh out.

Mark Coddington

Associate Professor, Washington and Lee University

this week

Bactrim Over The Counter

Bactrim No Rx

Flagyl Price

Glucophage Price

Bactrim Cost